982 Results found
Articles
White matter hyperintensities and headache in United States military veterans with mild traumatic brain injury
Abstract Objective: The objective of this study was to examine the association between white matter hyperintensities and migraine-like headache in United States military veterans with a history of mild traumatic brain injury. Background: White...
Published:
December 6, 2024Facial variant of epicrania fugax secondary to a cerebellopontine angle meningioma
Published:
November 29, 2024Relationship of dihydroergotamine pharmacokinetics, clinical efficacy, and nausea-A narrative review
Abstract Objective: To assess the relationships between dihydroergotamine (DHE) pharmacokinetic (PK) parameters, clinical efficacy, and nausea incidence to determine a DHE PK profile that optimizes efficacy while minimizing adverse events (AEs), particularly nausea. Background:...
Published:
November 29, 2024Relationship of dihydroergotamine pharmacokinetics, clinical efficacy, and nausea-A narrative review
Abstract Objective: To assess the relationships between dihydroergotamine (DHE) pharmacokinetic (PK) parameters, clinical efficacy, and nausea incidence to determine a DHE PK profile that optimizes efficacy while minimizing adverse events (AEs), particularly nausea. Background:...
Published:
November 29, 2024Relative frequency, characteristics, and disease burden of patients with migraine unsuitable for triptan treatment: A systematic literature review
Abstract Objective: This review was conducted to systematically identify evidence characterizing patients with migraine who are unsuitable for triptans. Background: Triptans are not suitable as first-line treatment for all patients with migraine due to...
Published:
November 29, 2024Relative frequency, characteristics, and disease burden of patients with migraine unsuitable for triptan treatment: A systematic literature review
Abstract Objective: This review was conducted to systematically identify evidence characterizing patients with migraine who are unsuitable for triptans. Background: Triptans are not suitable as first-line treatment for all patients with migraine due to...
Published:
November 29, 2024A post hoc analysis of migraine-associated symptoms from the phase 3 randomized, double-blind, sham-controlled Trial of External trigeminal nerve stimulation for the Acute treatment of Migraine (TEAM) study
Abstract Background: The Trial of External trigeminal nerve stimulation (eTNS) for the Acute treatment of Migraine (TEAM) study demonstrated that eTNS use during active migraine resulted in significantly higher rates of resolution of migraine-associated...
Published:
November 29, 2024Validity, reliability, and sensitivity to change of the Arabic version of the Migraine-Specific Quality-of-Life Questionnaire after prophylactic treatment
Abstract Background: The Migraine-Specific Quality-of-Life Questionnaire version 2.1 (MSQ 2.1) is one of the most frequently used tools in assessing the impact of migraine in clinical practice and in migraine research. This work aimed...
Published:
November 29, 2024Group text messaging as a residency teaching tool in outpatient neurology and headache: A mixed-methods observational study
Abstract Objective: To assess the feasibility and efficacy of group text messaging as a teaching tool to improve neurology resident knowledge and clinical pearl dissemination in an outpatient setting enriched with headache encounters, and...
Published:
November 29, 2024Deep brain stimulation for chronic refractory cluster headache: A case series about long-term outcomes and connectivity analysis
Abstract Objective: The aim of this study was to provide long-term clinical results-including “sweet spot” identification and connectomic imaging analysis-in a series of patients treated with deep brain stimulation for refractory chronic cluster headache....
Published:
November 29, 2024Anxiety, depression, and headache-related disability in a large pediatric clinic-based sample
Abstract Objective: To explore the relationships among anxiety, depression, and headache-related disability in a pediatric clinic-based retrospective cross-sectional study. Background: Anxiety and depression are commonly considered comorbidities of headache disorders and are frequently seen...
Published:
November 22, 2024Safety and tolerability of ubrogepant for the acute treatment of migraine in participants taking atogepant for the preventive treatment of episodic migraine: Results from the TANDEM study
Abstract Objective: To evaluate the safety and tolerability of ubrogepant for the acute treatment of migraine in participants taking atogepant for the preventive treatment of episodic migraine (EM). Background: Atogepant is an oral calcitonin...
Published:
November 22, 2024Occipital neuralgia as an initial manifestation of atypical Lemierre syndrome: A case report
Abstract Lemierre syndrome is a life-threatening but treatable septic thrombosis of the internal jugular vein (IJV) derived from a craniocervical bacterial infection. Metastatic septic embolization is common. However, diagnostic delay and poor prognosis remain...
Published:
November 22, 2024Headaches in Sjogren’s disease: A narrative review
Abstract Objective: To review the most common types of primary and secondary headaches that are associated with Sjogren’s disease (SjD). Background: Sjogren’s disease is a chronic systemic autoimmune disease that typically presents with xerophthalmia,...
Published:
November 22, 2024Comparative bioavailability of single-dose zavegepant during and between migraine attacks: A phase 1, randomized, open-label, fixed-sequence, two-period study
Abstract Objective: To compare the rate and extent of absorption of zavegepant 10 mg (therapeutic dose) or 20 mg (supratherapeutic dose) nasal spray during a migraine attack versus non-migraine period, assess safety, and explore...
Published:
November 15, 2024Genetically proxied liability to migraine and risk of intracranial aneurysm and subarachnoid hemorrhage
Abstract Background: Observational studies have reported inconsistent relationships between migraine and the risk of intracranial aneurysm and subarachnoid hemorrhage (SAH). Objective: To determine whether genetic liability to migraine is associated with risk of intracranial...
Published:
November 15, 2024Genetically proxied liability to migraine and risk of intracranial aneurysm and subarachnoid hemorrhage
Abstract Background: Observational studies have reported inconsistent relationships between migraine and the risk of intracranial aneurysm and subarachnoid hemorrhage (SAH). Objective: To determine whether genetic liability to migraine is associated with risk of intracranial...
Published:
November 15, 2024Associations of comorbid headache disorders and depression with leisure-time physical activity among 14,088 adults in The Brazilian Longitudinal Study of Adult Health
Abstract Background: While headache disorders are linked to low physical activity levels, the impact of depression on this relationship is unclear. Objective: To assess how single and comorbid diagnoses of migraine and tension-type headache...
Published:
November 15, 2024Magnetoencephalography studies in migraine and headache disorders: A systematic review
Abstract Background: Understanding the neural mechanisms underlying migraine and other primary headache disorders is critical for the development of long-term cures. Magnetoencephalography (MEG), an imaging modality that measures neuronal currents and cortical excitability with...
Published:
November 15, 2024Effects of multiple-dose administration of zavegepant nasal spray on the single-dose pharmacokinetics of ethinyl estradiol-levonorgestrel
Abstract Objective: The potential for drug-drug interaction of multiple-dose intranasal zavegepant on the single-dose oral contraceptive ethinyl estradiol and levonorgestrel (EE-LNG) was evaluated. Background: Zavegepant (as a nasal spray) is a calcitonin gene-related peptide...
Published:
November 8, 2024
